Search research articles
Contact Us
Filters
Showing results (51-60 of 60) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 60 results.
BMJ Case Reports
|
December 18, 2015
Tumefactive demyelination presenting during bevacizumab treatment
Claire M Rice, David Rossiter, Janev Fehmi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 29, 2021
Reduced expression of mitochondrial fumarate hydratase in progressive multiple sclerosis contributes to impaired in vitro mesenchymal stromal cell-mediated neuroprotection
Pamela Sarkar, Juliana Redondo, Kelly Hares, et al.
Nature Communications
|
August 9, 2022
An open-label pilot study of recombinant granulocyte-colony stimulating factor in Friedreich's ataxia
Kevin C Kemp, Anastasia Georgievskaya, Kelly Hares, et al.
Multiple Sclerosis and Related Disorders
|
April 9, 2022
Repeat infusion of autologous bone marrow cells in progressive multiple sclerosis - A phase I extension study (SIAMMS II)
Claire M Rice, Pamela Sarkar, Peter Walsh, et al.
BMJ Open
|
September 13, 2015
Repeat infusion of autologous bone marrow cells in multiple sclerosis: protocol for a phase I extension study (SIAMMS-II)
Claire M Rice, David I Marks, Peter Walsh, et al.
Annals of Neurology
|
March 14, 2018
Bone marrow transplantation stimulates neural repair in Friedreich's ataxia mice
Kevin C Kemp, Kelly Hares, Juliana Redondo, et al.
Annals of Neurology
|
December 24, 2016
Cytokine therapy-mediated neuroprotection in a Friedreich's ataxia mouse model
Kevin C Kemp, Nadia Cerminara, Kelly Hares, et al.
Brain : a Journal of Neurology
|
January 22, 2005
Abeta-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy
Neil J Scolding, Fady Joseph, Patricia A Kirby, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 27, 2017
Reduced cellularity of bone marrow in multiple sclerosis with decreased MSC expansion potential and premature ageing in vitro
Juliana Redondo, Pamela Sarkar, Kevin Kemp, et al.
Trials
|
October 16, 2015
Assessment of bone marrow-derived Cellular Therapy in progressive Multiple Sclerosis (ACTiMuS): study protocol for a randomised controlled trial
Claire M Rice, David I Marks, Yoav Ben-Shlomo, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 60) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 60 results.
BMJ Case Reports
|
December 18, 2015
Tumefactive demyelination presenting during bevacizumab treatment
Claire M Rice, David Rossiter, Janev Fehmi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 29, 2021
Reduced expression of mitochondrial fumarate hydratase in progressive multiple sclerosis contributes to impaired in vitro mesenchymal stromal cell-mediated neuroprotection
Pamela Sarkar, Juliana Redondo, Kelly Hares, et al.
Nature Communications
|
August 9, 2022
An open-label pilot study of recombinant granulocyte-colony stimulating factor in Friedreich's ataxia
Kevin C Kemp, Anastasia Georgievskaya, Kelly Hares, et al.
Multiple Sclerosis and Related Disorders
|
April 9, 2022
Repeat infusion of autologous bone marrow cells in progressive multiple sclerosis - A phase I extension study (SIAMMS II)
Claire M Rice, Pamela Sarkar, Peter Walsh, et al.
BMJ Open
|
September 13, 2015
Repeat infusion of autologous bone marrow cells in multiple sclerosis: protocol for a phase I extension study (SIAMMS-II)
Claire M Rice, David I Marks, Peter Walsh, et al.
Annals of Neurology
|
March 14, 2018
Bone marrow transplantation stimulates neural repair in Friedreich's ataxia mice
Kevin C Kemp, Kelly Hares, Juliana Redondo, et al.
Annals of Neurology
|
December 24, 2016
Cytokine therapy-mediated neuroprotection in a Friedreich's ataxia mouse model
Kevin C Kemp, Nadia Cerminara, Kelly Hares, et al.
Brain : a Journal of Neurology
|
January 22, 2005
Abeta-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy
Neil J Scolding, Fady Joseph, Patricia A Kirby, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 27, 2017
Reduced cellularity of bone marrow in multiple sclerosis with decreased MSC expansion potential and premature ageing in vitro
Juliana Redondo, Pamela Sarkar, Kevin Kemp, et al.
Trials
|
October 16, 2015
Assessment of bone marrow-derived Cellular Therapy in progressive Multiple Sclerosis (ACTiMuS): study protocol for a randomised controlled trial
Claire M Rice, David I Marks, Yoav Ben-Shlomo, et al.
Page
of 6